Cart
sales@molnova.com
Myristoyl-L-carnitine chloride
CAS No. 173686-73-2
Myristoyl-L-carnitine chloride( —— )
Catalog No. M34939 CAS No. 173686-73-2
Myristoyl-L-carnitine chloride (L-Myristoylcarnitine chloride) is one of the body's metabolites implicated in inherited metabolic disorders.Tetradecanoylcarnitine is a potential marker for the study of diabetes mellitus and autoimmune hepatitis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 47 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMyristoyl-L-carnitine chloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyristoyl-L-carnitine chloride (L-Myristoylcarnitine chloride) is one of the body's metabolites implicated in inherited metabolic disorders.Tetradecanoylcarnitine is a potential marker for the study of diabetes mellitus and autoimmune hepatitis.
-
DescriptionMyristoyl-L-Carnitine Chloride is a natural long-chain glycoline, amino acid derivative.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173686-73-2
-
Formula Weight408.015
-
Molecular FormulaC21H42ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](OC(CCCCCCCCCCCCC)=O)(C[N+](C)(C)C)CC(O)=O.[Cl-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stephanie E Reuter, et al. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann Clin Biochem. 2005 Sep;42(Pt 5):387-93.??
molnova catalog
related products
-
Chlorophos
Metrifonate (INN) or trichlorfon (USAN) is an irreversible organophosphate acetylcholinesterase inhibitor.
-
KIRA6
KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade.
-
CHD1Li 6.11
CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM).
